|Articles|April 11, 2020

Recalls That Should Be on Your Radar—Week of April 5, 2020

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Boston Scientific Corporation Issues Recall of Imager II Angiographic Catheters Due to Tip Detachment

Boston Scientific Corporation has issued a recall of Imager II angiographic catheters due to the possibility of tip detachment malfunctions. The catheters are used to deliver contrast agents to blood vessels including carotid arteries.

The catheter tip can become detached during a patient procedure or during procedure preparation. This may lead to additional procedures to remove the catheter tip from the patient’s blood vessel and increased the length of hospital stay. There is also the potential for serious adverse events including obstruction of embolism, stroke, or death.

There have been 9 injuries reported.

Read the recall statement.

H&C Food Inc. Issues Recall of Enoki Mushroom Because of Possible Health Risk

H&C Food has issued a recall of its enoki Mushroom due to the potential to be contaminated with Listeria monocytogenes.

Listeria monocytogenes can cause serious, even deadly, infections in older adults, the immunocompromised, and young children. In healthy individuals, there are typically only short term symptoms like fever, severe headache, nausea, stiffness, diarrhea, and abdominal pain.

No adverse health events have been reported to date in connection with this problem.

The products affected are enoki mushrooms from South Korea. The FDA began investigating an outbreak of Listeria associated with enoki mushrooms imported from South Korea which were sold by another firm in March.

Read the recall statement.


Related to this article

FAQ: What You Need to Know About West Nile Virus in 2026
After 2 adults died of West Nile virus in central North Carolina this month, this FAQ explains how the mosquito-borne virus spreads, who faces the greatest risk of severe neuroinvasive disease, and how clinicians can diagnose, manage, and help prevent infection when no vaccine or antiviral treatment exists.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.